Is a complete VBIO research report available?

No complete published report is available for Valion Bio, Inc. (VBIO) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Valion Bio, Inc. (VBIO)

NASDAQ: VBIO · USD

$0.28

-0.00 (-0.7%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first VBIO analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	889.8K
Net income (ttm)	-13.8M
EPS (ttm)	-$8.00
Shares out	3.2M
Volume	139,068
Beta	1.83

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -13.8M
EPS (ttm): -$8.00
Market cap: 889.8K

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All VBIO indicators

Market & fundamental data

Available fields

173

Groups with data

Currency

USD

Showing 173 of 173 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001787740
Company name	Valion Bio, Inc.
Country	United States
Country code	US
Cusip	888705308
Employees	52
Employees Change	45%
Employees Change Percent	642.9
Enterprise value	$10.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-11-11
Isin	US8887053085
Last refreshed	2026-07-31
Market cap	$889,829
Market cap category	Nano-Cap
Price	$0.28
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2834
Symbol	VBIO
Website	https://valionbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1,541.23%
FCF yield	-1,245.88%
P/B ratio	0.07x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-5,183.62%
EBITDA Margin	-5,180.17%
Net Income	$-13.8M
Net Income Growth Years	0%
Profit Per Employee	$-265,635
ROA	-36.18
Roa5y	-59.05
ROCE	-33.78
ROE	-182.2
Roe5y	-143.5
ROIC	-48.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-92.46%
Cagr3y	-85.14%
EPS Growth Quarters	5
EPS Growth Years	4
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$38.2M
Cash	$7.2M
Current Assets	$8.7M
Current Liabilities	$2.6M
Debt	$17M
Debt Equity	$1.54
Equity	$11.1M
Interest Coverage	-15.15
Liabilities	$27.2M
Long Term Assets	$29.6M
Long Term Liabilities	$24.5M
Net Cash	$-9.8M
Net Cash By Market Cap	$-1,096
Net Debt Equity	$0.89
Tangible Book Value	$5.4M
Tangible Book Value Per Share	$1.86
WACC	4.21

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.31
Net Working Capital	$-686,000
Quick ratio	2.76
Working Capital	$6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-316.46%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-92.45%
200-day SMA	1.24
3Y total return	-99.67%
50-day SMA	0.57
50-day SMA vs 200-day SMA	50under200
All Time High	11,050
All Time High Change	-100%
All Time High Date	2021-11-11
All Time Low	0.25
All Time Low Change	10.76%
All Time Low Date	2026-07-28
ATR	0.07
Beta	1.83
Beta1y	2.07
Beta2y	1.48
Ch YTD	-80.83
High	0.28
High52	5.6
High52 Date	2025-08-15
High52ch	-95.04%
Low	0.25
Low52	0.25
Low52 Date	2026-07-28
Low52ch	10.76%
Ma50ch	-50.91%
Price vs 200-day SMA	-77.51%
RSI	25.45
RSI Monthly	25.38
RSI Weekly	25.61
Sharpe ratio	-1.92x
Sortino ratio	-2.39
Total Return	-316.46%
Tr YTD	-80.83
Tr1m	-49.45%
Tr1w	-2.8%
Tr3m	-71.04%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-12.2M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,560,189%
Float Percent	79.99%
Shares Insiders	4.35%
Shares Institutions	13.17%
Shares Out	3,200,824
Shares Yo Y	316.46%
Short Float	10.31%
Short Ratio	1.11
Short Shares	8.24

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-11.8M
Adjusted OCF	-11,793,000
Average Volume	720,381.4x
Bv Per Share	3.84
CAPEX	$-45,000
Ch1m	-49.45
Ch1w	-2.8
Ch1y	-92.45
Ch3m	-71.04
Ch3y	-99.67
Ch6m	-77.4
Change	-0.71%
Change From Open	4.43
Close	0.28
Days Gap	-4.93
Depreciation Amortization	8,000
Dollar Volume	38,660.9
Earnings Date	2026-08-13
Earnings Time	amc
EBIT	$-12M
EBITDA	$-12M
EPS	$-8
F Score	2
FCF	$-11.2M
FCF EV Yield	-104.21x
FCF Per Share	$-3.49
Financing CF	18,221,000
Fiscal Year End	December
Founded	2,016
Goodwill	3,457,000
Investing CF	-186,000
Iprfo	-100
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-14
Last Report Date	2026-03-31
Last Split Date	2025-03-07
Last Split Type	Reverse
Last10k Filing Date	2026-03-30
Ma150	0.9
Ma150ch	-69.08%
Ma20	0.41
Ma20ch	-31.44%
Net CF	6,914,000
Next Earnings Date	2026-08-13
Open	0.27
Optionable	No
Position In Range	96.4
Post Close	0.28
Postmarket Change Percent	-1.51
Postmarket Price	$0.27
Ppne	22,730,000
Price Date	2026-07-30
Ptbv Ratio	0.17
Relative Volume	0.19x
Share Based Comp	672,000
Tr6m	-77.4%
Us State	Texas
Volume	139,068

Valion Bio, Inc. (VBIO)

Coverage state: Market snapshot only — no published research

Generate the first VBIO analysis

Price

Financial snapshot

Fair-value bridge

Latest news · VBIO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VBIO indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on VBIO

Frequently asked questions